Pharmaceuticals - King of Prussia, Pennsylvania, United States
ACQUIRED 10.26.18CURRENTLY FEATURED IN OUR PIPELINEInvestigative research on patented, novel, non-psychoactive therapeutics, using parenteral administration for targeted rescue and chronic treatment of convulsive disorders, including epilepsy and refractory epilepsy.Alternative therapeutic areas include pain, and targeted neurological encephalopathies. Human and Veterinary Applications.